Al-Marsad newspaper: The Telegraph published the results of experiments conducted on a new treatment called . AFM24For the treatment of cancer, as it has proven very successful, with patients, especially in the advanced stages of the disease, including cancer of the intestine, lung and pancreas.
The results revealed that a new immune cancer treatment called AFM24It stopped one in three tumors from growing, so it was called the “killer” of cancer.
The newspaper pointed out that the experiments were conducted on patients with the deadliest type, and the results showed that it redirects the killer immune cells in the body to kill tumors.
The Institute of Cancer Research in London, in cooperation with the Center the Royal Marsden The NHS pioneer in cancer treatment has a phase 1 trial in 24 patients with lethal tumors for which all drugs have failed.
And the treatment proved effective with eight of the 24 patients in the immunotherapy trial, and they noticed that their cancers stopped growing, especially two patients with bowel cancer and another with lung cancer, when they received immunotherapy, the tumor was reduced or stopped growing for more than three months.
The researchers said the drug acted as a fighter, targeting a protein that causes tumor growth without having to go through a complex process of re-engineering a patient’s cells.
The results, presented last week at the American Association for Cancer Research conference in New Orleans, revealed that the treatment has the potential to be safer and less complex than current cellular therapies.
Professor Christian Helen, CEO of the Institute of Cancer Research, praised the results of this new drug, saying: “This new treatment is very innovative because it finds a way to direct natural killer cells within the immune system to tumors without the need for complex and costly re-engineering of patient cells.”